MedTrace Logo

Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score

NCT07020546 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2025-07-09

No results posted yet for this study

Summary

Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.

Conditions

  • Infertility
  • Poor Ovarian Reserve
  • Embryo Growth Disorder
  • in Vitro Fertilization

Interventions

PROCEDURE

Ovarian Platelet-rich plasma (PRP) injections

This is a procedure that our patients receive at our clinic. We want to use the AI software to evaluate embryo development before and after treatment to see if there is a difference in embryo quality after PRP treatment within the same patient.

Sponsors & Collaborators

  • Generation Next Fertility

    lead OTHER

Principal Investigators

  • Jesse Hade, MD · Generation Next Fertility

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
47 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-08
Primary Completion
2026-06-30
Completion
2026-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07020546 on ClinicalTrials.gov